Nektar Therapeutics (NASDAQ:NKTR)

11.87
Delayed Data
As of May 22
 +0.29 / +2.50%
Today’s Change
9.51
Today|||52-Week Range
17.53
-23.42%
Year-to-Date

Today’s Trading

Previous close11.58
Today’s open11.58
Day’s range11.46 - 11.87
Volume939,444
Average volume (3 months)1,766,260
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)-26.19%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+34.77%
P/E ratio59.1
Price/Sales9.80
Price/Book42.87

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...+0.23+2.60%
PRAHPRA Health Sciences ...-0.01-0.03%
ABCOAdvisory Board Co+0.01+0.02%
KERXKeryx Biopharmaceuti...-0.33-3.10%
Data as of 3:59pm ET, 05/22/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers